Improvements in the minimum binding sequence of C5a: examination of His-67.
Or
Y S
YS
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064.
Clark
R F
RF
Lane
B
B
Mollison
K W
KW
Carter
G W
GW
Luly
J R
JR
D000595:Amino Acid Sequence; D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D015936:Complement C5a / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism*; D006168:Guinea Pigs; D006639:Histidine; D006801:Humans; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D009504:Neutrophils / Q000276:immunology; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000378:metabolism; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012867:Skin / Q000098:blood supply; D013329:Structure-Activity Relationship
D010446:Peptide Fragments; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement; D006639:Histidine; D015936:Complement C5a